CLINICAL_TRIALS
trial_result
· 2008-02-15
Clinical Trial Update: Evaluation of the Efficacy of Cesamet™ for the Treatment of Pain in Patients With Diabetic Peripheral Neuropathy [Phase 4]
Summary
A Phase 4 trial evaluating Cesamet (nabilone) for pain in diabetic peripheral neuropathy has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NEMA Research, Inc. | Conditions: Diabetic Neuropathies | Phase 4 | Status: COMPLETED